Loading...
Cetuximab in locally advanced head-and-neck cancer: defining the population
Encouraging data for targeted therapy in head-and-neck squamous cell carcinoma are opening new options for treatment. Phase III trials of cetuximab, an antibody directed against the epidermal growth factor receptor (egfr) have demonstrated benefit in the locally advanced and metastatic settings. Rec...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Multimed Inc.
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2913829/ https://ncbi.nlm.nih.gov/pubmed/20697514 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|